Trident Lifeline Share Price | Trident Lifeline Stock Screener
TLL
Pharmaceuticals
Track Trident Lifeline share price live with TickJournal's free stock screener.
Check TLL 52-week chart for the annual price range and momentum.
Use the Trident Lifeline stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Trident Lifeline Market Cap
₹305.45 Cr.
TLL P/E Ratio (TTM)
16.31
Trident Lifeline P/B Ratio
3.14
EPS (TTM)
₹16.32
Dividend Yield
-
Debt to Equity
0.62
TLL 52 Week High
-
Trident Lifeline 52 Week Low
-
Operating Margin
23.00%
Profit Margin
14.00%
TLL Revenue (TTM)
₹50.00
EBITDA
₹13.00
Net Income
₹7.00
Total Assets
₹237.00
Total Equity
₹100.00
Trident Lifeline Share Price Chart
Screen Trident Lifeline share price with an interactive chart. Analyse TLL price trends and volatility across different timeframes.
Trident Lifeline Company Profile - Fundamental Screener
Screen Trident Lifeline company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TLL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MKA01014
Trident Lifeline Balance Sheet Screener
Screen TLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 237 | 156 | 87 | 63 | 14 |
| Current Assets | 140 | 90 | 52 | 49 | 11 |
| Fixed Assets | 73 | 44 | 21 | 3 | 1 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 41 | 33 | 13 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 100 | 70 | 54 | 47 | 5 |
| Share Capital | 12 | 12 | 12 | 12 | 8 |
| Reserves & Surplus | 89 | 53 | 40 | 34 | -3 |
Trident Lifeline Income Statement Screener - Profit & Revenue Analysis
Screen Trident Lifeline income statement and profit fundamentals.
Analyze TLL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Trident Lifeline share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50 | 30 | 33 | 25 | 36 | 12 | 16 | 14 | 21 | 7 | 10 | 9 | 9 | 10 | 8 |
| Expenses | 37 | 21 | 25 | 18 | 26 | 8 | 11 | 11 | 17 | 6 | 8 | 7 | 7 | 7 | 6 |
| EBITDA | 13 | 10 | 9 | 7 | 10 | 5 | 5 | 4 | 4 | 2 | 3 | 2 | 3 | 2 | 2 |
| Operating Profit % | 23.00% | 20.00% | 22.00% | 22.00% | 25.00% | 34.00% | 26.00% | 19.00% | 12.00% | 20.00% | 22.00% | 20.00% | 23.00% | 21.00% | 18.00% |
| Depreciation | 1 | 3 | 1 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 6 | 7 | 4 | 6 | 4 | 4 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 |
| Tax | 4 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 7 | 5 | 5 | 3 | 6 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 |
| EPS | 5.81 | 3.72 | 4.27 | 2.66 | 6.15 | 2.42 | 2.69 | 1.99 | 1.41 | 0.94 | 1.48 | 1.22 | 1.72 | 1.77 | 1.15 |
Trident Lifeline Cash Flow Screener - Liquidity Fundamentals
Screen TLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -10 | 2 | -19 | 0 |
| Investing Activities | -14 | -20 | -10 | 0 |
| Financing Activities | 20 | 11 | 42 | 1 |
| Net Cash Flow | -4 | -7 | 14 | 0 |
Trident Lifeline Shareholding Pattern Screener
See Trident Lifeline shareholding pattern with promoter, FII, and DII holdings.
Check Trident Lifeline promoter holding and ownership changes for TLL on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.85% | 63.04% | 63.04% | 63.11% | 64.11% | 67.48% | 65.51% | 62.99% |
| FII Holding | 7.24% | 6.62% | 7.21% | 7.71% | 7.04% | 6.02% | 6.02% | 6.09% |
| DII Holding | 0.27% | 0.09% | 0.39% | 0.41% | 0.35% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.67% | 18.26% | 17.90% | 17.63% | 17.29% | 16.39% | 18.37% | 19.40% |
| Other Holding | 10.97% | 11.99% | 11.45% | 11.14% | 11.22% | 10.10% | 10.10% | 11.52% |
| Shareholder Count | 607 | 534 | 549 | 554 | 549 | 500 | 502 | 507 |
Trident Lifeline Share Dividend Screener - Share Yield Analysis
Check Trident Lifeline dividend history with payout and yield data.
View Trident Lifeline dividend details including ex-dates and amounts for TLL stock.
Trident Lifeline Stock Index Membership
See which indices include Trident Lifeline stock.
Check TLL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Trident Lifeline Market Events Screener - Corporate Actions
Get Trident Lifeline corporate actions including splits, bonuses, and buybacks.
Check Trident Lifeline stock events that may affect TLL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.35% | ||
| Annual General Meeting | NA | 18.05% | ||
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | -0.97% |
| 2026-01-17 | 2026-01-17 | Quarterly Result Announcement | NA | 5.78% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 1.43% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 1.19% |
| 2025-05-09 | 2025-05-09 | Extraordinary General Meeting | NA | 13.60% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 5.19% |
| 2025-01-22 | 2025-01-22 | Quarterly Result Announcement | NA | 5.83% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 4.93% |
Trident Lifeline Competitors Screener - Peer Comparison
Screen TLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Trident Lifeline Company Announcements - News Screener
Screen TLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-12 | Appointment Of Internal Auditor | - |
| 2026-05-12 | Result- Financial Result For Half Year And Year Ended On 31.03.2026 | - |
| 2026-05-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On May 07 2026 | - |
| 2026-05-04 | Update on board meeting | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-29 | Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Half Year And Year Ended 31St March 2026 | - |
| 2026-04-24 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-04-17 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-03-28 | Outcome Of Separate Meeting Of Independent Directors Held On 28.03.2026 | - |
| 2026-03-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-18 | Announcement under Regulation 30 (LODR)-Acquisition | - |